The literature confirms that factor V Leiden and prothrombin G20210A are considered to be predominant genetic risk factors for VTE in Caucasian populations, and heterozygotes have a 20-fold increased risk of VTE, while individuals with the prothrombin G20210A allele had an increased about four times risk of thrombosis [21]. This evidence concerns the gene F2 and Venous thrombosis.